Research group questions price of GlaxoSmithKline’s new asthma drug – Philadelphia Business Journal


Philadelphia Business Journal

Research group questions price of GlaxoSmithKline's new asthma drug
Philadelphia Business Journal
The Institute for Clinical and Economic Review, a Boston-based nonprofit research organization that studies the effectiveness and value of drugs, issued a draft report Monday that said the price of GlaxoSmithKline's new asthma medicine Nucala should be
Independent group says new Glaxo asthma drug far too expensiveReuters

all 15 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.